Disc Medicine, Inc.
IRON
Classement en actions
#4957
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Prix de l'action
$75.39
Dernière synchronisation: 2026-10-22
Capitalisation boursière
$2.89B
Changement (1 jour)
-0.80%
Changement (1 an)
-9.92%
Pays
US
Échange Disc Medicine, Inc. (IRON)
Catégorie
Healthcare
Ratio P/B pour Disc Medicine, Inc. (IRON)
Ratio P/B au October 2026 TTM : 4.65
Selon les derniers rapports financiers et le cours de l'action de Disc Medicine, Inc., le ratio cours/valeur comptable actuel (TTM) est 4.65. À la fin de 2024, le ratio P/B était de 3.95.
Historique du ratio P/B pour Disc Medicine, Inc. de 2020 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 4.65 | 22.73% |
| 2025 | 3.79 | -3.98% |
| 2024 | 3.95 | 5.64% |
| 2023 | 3.73 | 3,089.41% |
| 2022 | 0.12 | -132.23% |
| 2021 | -0.36 | -95.22% |
| 2020 | -7.61 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.6964 | 43.96% |
US
|
|
| 13.6307 | 193.03% |
US
|
|
| 4.4521 | -4.29% |
AU
|
|
| 4.2241 | -9.19% |
BE
|
|
| 6.3632 | 36.80% |
NL
|
